
Harnessing AI and data science to discover life-changing medicines at AstraZeneca
The complexity of antibodies requires thinking about biological processes at the molecular level, says Weatherall: “In the past this was a laborious process, but we now have the capacity to screen up to hundreds of millions of antibody sequences per experiment . ability to train machine learning models, which means that in the future we…